[1] Siegel RL, Miller KD, Jemal A.Cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(1): 7-30.
[2] Harbeck N, Penault-Llorca F, Cortes J, et al.Breast cancer[J]. Nat Rev Dis Primers, 2019, 5(1): 66.
[3] Becker A, Thakur BK, Weiss JM, et al.Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis[J]. Cancer Cell, 2016, 30(6): 836-848.
[4] Johnstone RM, Adam M, Hammond JR, et al.Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes)[J]. J Biol Chem, 1987, 262(19): 9412-9420.
[5] Lambertz U, Oviedo OM, Vasconcelos EJ, et al.Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging[J]. Bmc Genomics, 2015, 16: 151.
[6] Kalluri R, Lebleu VS.The biology, function , and biomedical applications of exosomes[J]. Science (American Association for the Advancement of Science), 2020, 367(6478): u6977.
[7] Liu T, Hooda J, Atkinson JM, et al.Exosomes in Breast Cancer-Mechanisms of Action and Clinical Potential[J]. Mol Cancer Res, 2021, 19(6): 935-945.
[8] Dutta S, Warshall C, Bandyopadhyay C, et al.Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells[J]. Plos One, 2014, 9(5): e97580.
[9] Yan W, Wu X, Zhou W, et al.Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells[J]. Nat Cell Biol, 2018, 20(5): 597-609.
[10] Liu T, Hooda J, Atkinson JM, et al.Exosomes in Breast Cancer-Mechanisms of Action and Clinical Potential[J]. Mol Cancer Res, 2021, 19(6): 935-945.
[11] Wang S, Su X, Xu M, et al.Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway[J]. Stem Cell Res Ther, 2019, 10(1): 117.
[12] Luga V, Zhang L, Viloria-Petit AM, et al.Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration[J]. Cell, 2012, 151(7): 1542-1556.
[13] Li K, Liu T, Chen J, et al.Survivin in breast cancer-derived exosomes activates fibroblasts by up-regulating SOD1, whose feedback promotes cancer proliferation and metastasis[J]. J Biol Chem, 2020, 295(40): 13737-13752.
[14] Zhou W, Fong MY, Min Y, et al.Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis[J]. Cancer Cell, 2014, 25(4): 501-515.
[15] Fong MY, Zhou W, Liu L, et al.Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis[J]. Nat Cell Biol, 2015, 17(2): 183-194.
[16] Jafari R, Rahbarghazi R, Ahmadi M, et al.Hypoxic exosomes orchestrate tumorigenesis: molecular mechanisms and therapeutic implications[J]. J Transl Med, 2020, 18(1): 474.
[17] Kosaka N, Iguchi H, Hagiwara K, et al.Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis[J]. J Biol Chem, 2013, 288(15): 10849-10859.
[18] Hou Y, Fan L, Li H.Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma[J]. Mol Ther Nucleic Acids, 2021, 24: 92-103.
[19] Chalmin F, Ladoire S, Mignot G, et al.Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cells Oncogenic miR-27a delivered by exosomes binds to SFRP1 and promotes angiogenesis in renal clear cell carcinoma[J]. J Clin Invest, 2010, 120(2): 457-471.
[20] Ham S, Lima LG, Chai E, et al.Breast Cancer-Derived Exosomes Alter Macrophage Polarization via gp130/STAT3 Signaling[J]. Front Immunol, 2018, 9: 871.
[21] Chen G, Huang AC, Zhang W, et al.Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response[J]. Nature, 2018, 560(7718): 382-386.
[22] Chow A, Zhou W, Liu L, et al.Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-kappaB[J]. Sci Rep, 2014, 4: 5750.
[23] Mao L, Li J, Chen WX, et al.Exosomes decrease sensitivity of breast cancer cells to adriamycin by delivering microRNAs[J]. Tumour Biol, 2016, 37(4): 5247-5256.
[24] Yang Q, Zhao S, Shi Z, et al.Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling[J]. J Exp Clin Cancer Res, 2021, 40(1): 120.
[25] Cornell L, Wander SA, Visal T, et al.MicroRNA-Mediated Suppression of the TGF-beta Pathway Confers Transmissible and Reversible CDK4/6 Inhibitor Resistance[J]. Cell Rep, 2019, 26(10): 2667-2680.
[26] Gao Y, Li X, Zeng C, et al.CD63+ Cancer-Associated Fibroblasts Confer Tamoxifen Resistance to Breast Cancer Cells through Exosomal miR-22[J]. Adv Sci (Weinh), 2020, 7(21): 2002518.
[27] Weaver O, Leung J.Biomarkers and Imaging of Breast Cancer[J]. AJR Am J Roentgenol, 2018, 210(2): 271-278.
[28] Hannafon BN, Trigoso YD, Calloway CL, et al.Plasma exosome microRNAs are indicative of breast cancer[J]. Breast Cancer Res, 2016, 18(1): 90.
[29] Wu X, Somlo G, Yu Y, et al.De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer[J]. J Transl Med, 2012, 10: 42.
[30] Kosgodage US, Trindade RP, Thompson PR, et al.Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy[J]. Int J Mol Sci, 2017, 18(5): 1007.
[31] Nishida-Aoki N, Tominaga N, Takeshita F, et al.Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis[J]. Mol Ther, 2017, 25(1): 181-191.
[32] Duan H, Liu Y, Gao Z, et al.Recent advances in drug delivery systems for targeting cancer stem cells[J]. Acta Pharm Sin B, 2021, 11(1): 55-70. |
